Reneuron Share Discussion Threads

[dickbush] 27/9/2019 13:51

We'll have to wait and see, but, to me, this is a really major, price sensitive, disclosure. Right now, Reneuron has two clinical trials running and this is the only one that has passed its trials with flying colours. The CTX/Stroke trial data, to my non-medical eye, looked mediocre, and didn't excite the market either: the stock price drifted all the way down below 50p following that data. QED, the share price is hanging on the RP results. Admittedly, further deals like Fosun Pharma could change that.

[jensonbensonjohnson] 27/9/2019 12:06

There will be an RNS beforehand, definitely.

[dickbush] 27/9/2019 11:56

Thanks, Lauders for that link. A very good presentation. Maybe he's worth all the money he's getting.

One thought: whatever they are going to show in the States in mid-October, shouldn't there be an RNS before the meeting? This would, I assume, be price sensitive information.

[martinfrench] 27/9/2019 11:42

As for the October updates, that will be the final confirmation for me not that I think we need it. Fairly sure the new cohort will be good, but more interested in the earlier ones as this will confirm the long term one off effect of stem cells

[martinfrench] 27/9/2019 11:35

Well lauders this used to be the main Rene board but post more on LSE these days.

I have been in Rene over ten years and prob never again as hate the pace of biotechs, but this one is nearing the end.

Have 10k shares and routinely buy around 2 quid, which is quite a lot in a biotech but I am confident this time.

[lauders] 27/9/2019 11:13

Thanks again then martinfrench. Please contribute more here ;-) I look-in over on the LSE but like to post here. As we approach October things may build in anticipation of the upcoming update. Could get quite lively.

[supernumerary] 27/9/2019 11:08

I thought that as usual the q&a session was the most interesting part - from about 20mins in. In particular I was pleased to hear they're actively looking at AMD, so thanks to whoever asked the question. That's an immense opportunity and they really need to be pushing it hard.

[martinfrench] 27/9/2019 10:12

hey thats me! fame at last.

the bit at 10:57 was among the interesting bits, though most of it was to be honest.

[lauders] 27/9/2019 05:13

Toptiger on the LSE BB pointed out the video below to the board yesterday:

[volsung] 26/9/2019 13:15

Its the Ken Chung effect in action. Keep posting Kenny!!

[dickbush] 26/9/2019 12:30

What's the news, Rayrac. I saw 100,000 sold at 201p, and the stock is acting like that rid us of an overhang. I now see that a block of 100,00 were crossed afterwards..

[rayrac] 25/9/2019 11:02

Woodford effect! News driven...ker chung 🤕🤡

[volsung] 25/9/2019 10:51

See you're back Ken. Usually a good sign :)

[ken chung] 25/9/2019 10:34

50p coming.Lemmings and mushrooms only.

[lauders] 22/9/2019 05:42

The most recent presentation from the company shows the future potential we are all here for, not long to wait for the next update.



Always worth repeating the summary of any presentation:

Global leader in cell-based therapeutics – sites in UK and Boston, US

Allogeneic stem cell technology platforms – patented, scalable & cost effective

Targeting diseases with large unmet medical needs

Significant clinical milestones in retinal and stroke programmes over the next 24 months

Near/medium term opportunities for value-generating partnering/collaboration deals

[iammiracleman] 19/9/2019 10:25

Anyone attend Reneuron presenting during the Shares evening at the Novotel in London last night?

[red army] 16/9/2019 11:28

Joined you guys this morning and bought some as chart suggesting a good entry point with a target price of £6.15p

[masingi] 13/9/2019 21:52

To be fair, all we are seeing now is day-tradey stuff. In reality, nothing but news matters with this share.

[rayrac] 13/9/2019 12:11

Needs a reason?

[rrb] 13/9/2019 11:14

Held support again. Heading back to 250p short term.

[outsizeclothes.com] 13/9/2019 10:38

I'd now count any break above £2 as having formed a "triple bottom"